Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4164-4174

  Xia, Weiya ^a   Lau, Yiu Keung ^a   Zhang, Hua Zhong ^a   Xiao, Fen Yuan ^b   Johnston, Dennis A ^a   Liu, Ai Ru ^c   Li, Lei ^c   Katz, Ruth L ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0033372557     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Ahomadegbe, J. C., Barrois, M., Fogel, S., Le Bihan, M. L., Douc-Rasy, S., Duvillard, P., Armand, J. P., and Riou, G. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome: frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene, 10: 1217-1227, 1995.
2. Sozzi, G., Miozzo, M., Tagliabue, E., Calderone, C., Lombardi, L., Pilotti, S., Pastorino, U., Pierotti, M. A., and Della Porta, G. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res., 51: 400-404, 1991.
3. Watling, D. L., Gown, A. M., and Coltrera, M. D. Overexpression of p53 in head and neck cancer. Head Neck, 14: 437-444, 1992.
4. Yamamoto, T., Kamata, N., Kawano, H., Shimizu, S., Kuroki, T., Toyoshima, K., Rikimaru, K., Nomura, N., Ishizaki, R., Pastan, I., et al. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res., 46: 414-416, 1986.
5. Field, J. K., Spandidos, D. A., Stell, P. M., Vaughan, E. D., Evan, G. I., and Moore, J. P. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene, 4: 1463-1468, 1989.
6. Berenson, J. R., Yang, J., and Mickel, R. A. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene, 4: 1111-1116, 1989.
7. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203-212, 1990.
8. Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., and Shoyab, M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA, 90: 1746-1750, 1993.
9. Khazaie, K., Schirrmacher, V., and Lichtner, R. B. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev., 12: 255-274, 1993.
10. Santini, J., Formento, J. L., Francoual, M., Milano, G., Schneider, M., Dassonville, O., and Demard, F. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck, 13: 132-139, 1991.
11. Alimandi, M., Romano, A., Curia, M. C., Muraro, R., Fedi, P., Aaronson, S. A., Di Fiore, P. P., and Kraus, M. H. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene, 10: 1813-1821, 1995.
12. Plowman, G. D., Whitney, G. S., Neubauer, M. G., Green, J. M., McDonald, V. L., Todaro, G. J., and Shoyab, M. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Natl. Acad. Sci. USA, 87: 4905-4909, 1990.
13. Kokai, Y., Myers, J. N., Wada, T., Brown, V. I., LeVea, C. M., Davis, J. G., Dobashi, K., and Greene, M. I. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell, 58: 287-292, 1989.
14. Bargmann, C. I., Hung, M. C., and Weinberg, R. A. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature (Lond.), 319: 226-230, 1986.
15. Schechter, A. L., Hung, M. C., Vaidyanathan, L., Weinberg, R. A., Yang-Feng, T. L., Francke, U., Ullrich, A., and Coussens, L. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science (Washington DC), 229: 976-978, 1985.
16. Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., and Yamamoto, T. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science (Washington DC), 232: 1644-1646, 1986.
17. Coussens, L., Yang-Feng, T. L., Liao, Y. C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science (Washington DC), 230: 1132-1139, 1985.
18. Stern, D. F., Heffernan, P. A., and Weinberg, R. A. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol. Cell. Biol., 6: 1729-1740, 1986.
19. Yarden, Y., and Ullrich, A. Growth factor receptor tyrosine kinases. Annu. Rev. Biochem., 57: 443-478, 1988.
20. Xie, Y., Li, K., and Hung, M. C. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu. Oncogene, 10: 2409-2413, 1995.
21. Xie, Y., Pendergast, A. M., and Hung, M. C. Dominant-negative mutants of Grb2 induced reversal of the transformed phenotypes caused by the point mutation-activated rat HER-2/Neu. J. Biol. Chem., 270: 30717-30724, 1995.
22. Yu, D., Wang, S. S., Dulski, K. M., Tsai, C. M., Nicolson, G. L., and Hung, M. C. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res., 54: 3260-3266, 1994.
23. Kern, J. A., Schwartz, D. A., Nordberg, J. E., Weiner, D. B., Greene, M. I., Torney, L., and Robinson, R. A. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res., 50: 5184-5187, 1990.
24. Schneider, P. M., Hung, M. C., Chiocca, S. M., Manning, J., Zhao, X. Y., Fang, K., and Roth, J. A. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res., 49: 4968-4971, 1989.
25. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
26. Zhang, X., Silva, E., Gershenson, D., and Hung, M. C. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract. Oncogene, 4: 985-989, 1989.
27. Xia, W., Lau, Y-K., Zhang, H-Z., Liu, A-R., Kiyokawa, N., Clayman, G. L., Katz, R. L., and Hung, M-C. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin. Cancer Res., 3: 3-9, 1997.
28. Kraus, M. H., Fedi, P., Starks, V., Muraro, R., and Aaronson, S. A. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells. Proc. Natl. Acad. Sci. USA, 90: 2900-2904, 1993.
29. Prigent, S. A., Lemoine, N. R., Hughes, C. M., Plowman, G. D., Selden, C., and Gullick, W. J. Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene, 7: 1273-1278, 1992.
30. Lemoine, N. R., Lobresco, M., Leung, H., Barton, C., Hughes, C. M., Prigent, S. A., Gullick, W. J., and Kloppel, G. The erbB-3 gene in human pancreatic cancer. J. Pathol., 168: 269-273, 1992.
31. Rajkumar, T., Gooden, C. S., Lemoine, N. R., Gullick, W. J., and Goden, C. S. Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1. J. Pathol., 170: 271-278, 1993.
32. Yi, E. S., Harclerode, D., Gondo, M., Stephenson, M., Brown, R. W., Younes, M., and Cagle, P. T. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas. Mod. Pathol., 10: 142-148, 1997.
33. Fedi, P., Pierce, J. H., di Fiore, P. P., and Kraus, M. H. Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C γ or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members. Mol. Cell. Biol., 14: 492-500, 1994.
34. erbB4 receptor. J. Biol. Chem., 268: 18407-18410, 1993.
35. Haugen, D. R., Akslen, L. A., Varhaug, J. E., and Lillehaug, J. R. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. Cancer Res., 56: 1184-1188, 1996.
36. Carinci, F., Farina, A., Longhini, L., Urso, R. G., Pelucchi, S., and Calearo, C. Is the new TNM (1997) the best system for predicting prognosis? Int. J. Oral Maxillofac. Surg., 28: 203-205, 1997.
37. Hsu, S. M., and Raine, L. Discovery of a high affinity of Phaseolus vulgaris agglutinin (PHA) with gastrin-secreting cells. Am. J. Clin. Pathol., 77: 396-400, 1982.
38. Hsu, S. M., Raine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
39. Kim, H-K., Sierke, S. L., and Koland, J. G. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB-3 gene product. J. Biol. Chem., 269: 24747-24755, 1994.
40. Zhang, L., Chang, C. J., Bacus, S. S., and Hung, M. C. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Res., 55: 3890-3896, 1995.
41. Zhang, L., and Hung, M. C. Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene, 12: 571-576, 1996.
42. De Potter, C. R., Quatacker, J., Aertens, G., Van Daele, S., Pauwels, C., Verhofstede, C., Eechaute, W., and Roels, H. The subcellular localization of the neu protein in human normal and neoplastic cells. Int. J. Cancer, 44: 969-974, 1989.
43. De Potter, C., Beghin, A. P., Makar, D., Vandekerckhove, J., and Roels, H. J. The neu-oncogene protein as predictive factor for haematogenous metastases in breast cancer patients. Int. J. Cancer, 45: 55-58, 1990.
44. Press, M. F., Hung, G., Godolphin, W., and Slamon, D. J. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res., 54: 2771-2777, 1994.
45. Gusterson, B. A., Guillick, W. J., Vener, D. J., Powles, T. J., Elliott, C., Ashley, S., Tidy, A., and Harrison, S. Immunohistochemical localization of c-erbB-2 in human breast carcinomas. Br. J. Cancer, 58: 453-457, 1988.
46. Xie, Y., and Hung, M. C. Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. Biochem. Biophys. Res. Commun., 203: 1589-1598, 1994.
47. Marti, U., Burwen, S. J., Wells, A., Barker, M. E., Huling, S., Feren, A. M., and Jones, A. L. Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology, 13: 15-20, 1991.
48. Holt, S. J., Alexander, P., Imman, C. B., and Davies, D. E. Epidermal growth factor induced tyrosine phosphorylation of nuclear proteins associated with translocation of epidermal growth factor receptor into the nucleus. Biochem. Pharmacol., 47: 117-126, 1994.
49. Simpson, B. J., Weatherill, J., Miller, E. P., Lessells, A. M., Langdon, S. P., and Miller, W. R. c-erbB-3 protein expression in ovarian tumours. Br. J. Cancer, 71: 758-762, 1995.
50. Lemoine, N. R., Barnes, D. M., Hollywood, D. P., Hughes, C. M., Smith, P., Dublin, E., Prigent, S. A., Gullick, W. J., and Hurst, H. C. Expression of the ERBB3 gene product in breast cancer. Br. J. Cancer, 66: 1116-1121, 1992.
51. Katoh, M., Yazaki, Y., Sugimura, T., and Terada, M. c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase. Biochem. Biophys. Res. Commun., 192: 1189-1197, 1993.
52. Velu, T. J., Beguinot, L., Vass, W. C., Willingham, M. C., Merlino, G. T., Pastan, I., and Lowy, D. R. Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. Science (Washington DC), 238: 1408-1410, 1987.
53. Di Fiore, P. P., Pierce, J. H., Fleming, T. P., Hazan, R., Ullrich, A., King, C. R., Schlessinger, J., and Aaronson, S. A. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell, 51: 1063-1070, 1987.
54. Riedel, H., Massoglia, S., Schlessinger, J., and Ullrich, A. Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts. Proc. Natl. Acad. Sci. USA, 85: 1477-1481, 1988.